FDA Approves OXYCODONE HYDROCHLORIDE — Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals, Inc. received FDA approval for its Abbreviated New Drug Application #ANDA204603 to manufacture Oxycodone Hydrochloride on April 29, 2015, impacting the market by potentially increasing the supply of this oral pain medication and increasing competition in the generic opioid segment. The authorization of this formulation is expected to enhance generic availability, potentially mitigating price fluctuations and increasing accessibility for patients reliant on this specific drug substance.